Stefan Oschmann Appointed New Executive Board Chairman of Merck

14-Oct-2015 - Germany

In its meeting, the Board of Partners of E. Merck KG appointed Stefan Oschmann (58) as new Chairman of the Executive Board and CEO of Merck KGaA. The appointment will take effect with the end of the Annual General Meeting on April 29, 2016. Stefan Oschmann will succeed Karl-Ludwig Kley (64) who will retire after then nine years as head of Merck.

Merck KGaA

Stefan Oschmann

Stefan Oschman has been a member of the Executive Board of Merck since 2011. He was initially in charge of the pharma business before being appointed as Deputy Chairman of the Executive Board and Deputy CEO at the beginning of 2015, responsible for strategy and innovation.

Prior to joining Merck, Stefan Oschmann worked for more than 20 years for U.S. pharma company MSD Merck Sharp & Dohme. He is president of the IFPMA (International Federation of Pharmaceutical Manufacturers & Associations) and Vice President of EFPIA (European Federation of Pharmaceutical Industries and Associations).

Karl-Ludwig Kley had already been a member of the Supervisory Board of Merck KGaA and the Board of Partners of E. Merck KG since 2004. In 2006 he became Deputy Chairman of the Executive Board of Merck before taking over as Chairman in 2007. Prior to that, he was Chief Financial Officer at Deutsche Lufthansa for eight years and joined the airline’s supervisory board in 2013. He is Deputy Chairman of the supervisory board of BMW and member of the supervisory board of Bertelsmann. In addition, he is vice president of the German Chemicals Association (VCI) and member of the steering committee of the Federation of German Industries (BDI).

Other news from the department people

Most read news

More news from our other portals

So close that even
molecules turn red...